Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.

Muyanja E, Ssemaganda A, Ngauv P, Cubas R, Perrin H, Srinivasan D, Canderan G, Lawson B, Kopycinski J, Graham AS, Rowe DK, Smith MJ, Isern S, Michael S, Silvestri G, Vanderford TH, Castro E, Pantaleo G, Singer J, Gillmour J, Kiwanuka N, Nanvubya A, Schmidt C, Birungi J, Cox J, Haddad EK, Kaleebu P, Fast P, Sekaly RP, Trautmann L, Gaucher D.

J Clin Invest. 2014 Jul;124(7):3147-58. doi: 10.1172/JCI75429. Epub 2014 Jun 9. Erratum in: J Clin Invest. 2014 Oct 1;124(10):4669. Gaucher, Denis [Added].

2.

Release of dengue virus genome induced by a peptide inhibitor.

Lok SM, Costin JM, Hrobowski YM, Hoffmann AR, Rowe DK, Kukkaro P, Holdaway H, Chipman P, Fontaine KA, Holbrook MR, Garry RF, Kostyuchenko V, Wimley WC, Isern S, Rossmann MG, Michael SF.

PLoS One. 2012;7(11):e50995. doi: 10.1371/journal.pone.0050995. Epub 2012 Nov 30.

3.

Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.

Costin JM, Zaitseva E, Kahle KM, Nicholson CO, Rowe DK, Graham AS, Bazzone LE, Hogancamp G, Figueroa Sierra M, Fong RH, Yang ST, Lin L, Robinson JE, Doranz BJ, Chernomordik LV, Michael SF, Schieffelin JS, Isern S.

J Virol. 2013 Jan;87(1):52-66. doi: 10.1128/JVI.02273-12. Epub 2012 Oct 17.

4.

Viral entry inhibitors block dengue antibody-dependent enhancement in vitro.

Nicholson CO, Costin JM, Rowe DK, Lin L, Jenwitheesuk E, Samudrala R, Isern S, Michael SF.

Antiviral Res. 2011 Jan;89(1):71-4. doi: 10.1016/j.antiviral.2010.11.008. Epub 2010 Nov 18.

PMID:
21093488
5.

A rapid method to score stream reaches based on the overall performance of their main ecological functions.

Rowe DK, Parkyn S, Quinn J, Collier K, Hatton C, Joy MK, Maxted J, Moore S.

Environ Manage. 2009 Jun;43(6):1287-300. doi: 10.1007/s00267-009-9302-z. Epub 2009 May 12.

PMID:
19434446

Supplemental Content

Support Center